Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Open innovation in neuroscience research and drug discovery:

Open innovation in neuroscience research and drug discovery: The pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation. Examples of the different types of models employed are discussed and some, but not all, of these have been used to promote research and drug discovery for central nervous system disorders. Some are completely open access, while others have some intellectual property restrictions. Going forward, more ways of promoting open innovation and the sharing of best practice, especially in the neurosciences, will stimulate research and hopefully accelerate new medicines development. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Brain and Neuroscience Advances SAGE

Open innovation in neuroscience research and drug discovery:

Open innovation in neuroscience research and drug discovery:

Brain and Neuroscience Advances , Volume 2: 1 – Sep 13, 2018

Abstract

The pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation. Examples of the different types of models employed are discussed and some, but not all, of these have been used to promote research and drug discovery for central nervous system disorders. Some are completely open access, while others have some intellectual property restrictions. Going forward, more ways of promoting open innovation and the sharing of best practice, especially in the neurosciences, will stimulate research and hopefully accelerate new medicines development.

Loading next page...
 
/lp/sage/open-innovation-in-neuroscience-research-and-drug-discovery-bFyy8VqRVv

References (42)

Publisher
SAGE
Copyright
Copyright © 2022 by SAGE Publications Ltd and British Neuroscience Association, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
ISSN
2398-2128
eISSN
2398-2128
DOI
10.1177/2398212818799270
Publisher site
See Article on Publisher Site

Abstract

The pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation. Examples of the different types of models employed are discussed and some, but not all, of these have been used to promote research and drug discovery for central nervous system disorders. Some are completely open access, while others have some intellectual property restrictions. Going forward, more ways of promoting open innovation and the sharing of best practice, especially in the neurosciences, will stimulate research and hopefully accelerate new medicines development.

Journal

Brain and Neuroscience AdvancesSAGE

Published: Sep 13, 2018

Keywords: Open innovation; central nervous system disorders; precompetitive collaboration

There are no references for this article.